Related Experiment Video
Updated: Jul 14, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Development of prophylactic HPV vaccines.
1Deutsches Krebsforschungszentrum Heidelberg, Heidelberg, Germany. l.gissmann@dkfz.de
Collegium Antropologicum
|June 30, 2007
Summary
Human papillomavirus (HPV) vaccination prevents persistent infections and precancerous lesions. HPV vaccines, particularly for high-risk types 16 and 18, show significant efficacy in preventing cervical cancer precursors.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Persistent infection with high-risk Human Papillomaviruses (HPV) is a primary risk factor for cervical cancer.
- HPV types 16 and 18 are responsible for approximately 70% of cervical cancer cases globally.
- Neutralizing antibodies targeting L1 protein epitopes, induced by virus-like particles (VLPs), confer protection against HPV infection.
Purpose of the Study:
- To evaluate the efficacy of HPV vaccines in preventing cervical cancer.
- To assess the safety and immunogenicity of HPV 16 and 18 VLP vaccines.
- To discuss ongoing questions regarding HPV vaccine effectiveness and accessibility.
Main Methods:
- Large-scale production of recombinant HPV 16 and 18 virus-like particles (VLPs).
- Clinical trials involving over 25,000 women to assess vaccine safety, immunogenicity, and efficacy.
- Analysis of protection against persistent HPV infection and development of cervical precursor lesions.
Main Results:
- HPV 16 and 18 VLP vaccines demonstrated protection against persistent HPV infection.
- Vaccination significantly reduced the development of cervical precancerous lesions.
- Over 25,000 women participated in efficacy trials, supporting vaccine effectiveness.
Conclusions:
- Existing data strongly support the efficacy of HPV vaccines in preventing HPV-related cervical disease.
- The licensing of HPV vaccines in several countries marks a significant advancement in cervical cancer prevention.
- Further research is needed on long-term protection, post-exposure strategies, and vaccine accessibility in low-resource settings.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations
Overview
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...